- Home
- CDXS vs PINE Comparison
CDXS vs PINE Comparison
Compare CDXS & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- PINE
- Stock Information
- Founded
- CDXS 2002
- PINE 2019
- Country
- CDXS United States
- PINE United States
- Employees
- CDXS N/A
- PINE N/A
- Industry
- CDXS Major Chemicals
- PINE Real Estate Investment Trusts
- Sector
- CDXS Industrials
- PINE Real Estate
- Exchange
- CDXS Nasdaq
- PINE Nasdaq
- Market Cap
- CDXS 201.3M
- PINE 219.7M
- IPO Year
- CDXS 2010
- PINE 2019
- Fundamental
- Price
- CDXS $2.30
- PINE $15.32
- Analyst Decision
- CDXS Buy
- PINE Strong Buy
- Analyst Count
- CDXS 2
- PINE 8
- Target Price
- CDXS $11.00
- PINE $19.00
- AVG Volume (30 Days)
- CDXS 1.0M
- PINE 63.8K
- Earning Date
- CDXS 05-14-2025
- PINE 07-17-2025
- Dividend Yield
- CDXS N/A
- PINE 7.44%
- EPS Growth
- CDXS N/A
- PINE N/A
- EPS
- CDXS N/A
- PINE 0.07
- Revenue
- CDXS $49,815,000.00
- PINE $53,967,000.00
- Revenue This Year
- CDXS $2.41
- PINE $7.94
- Revenue Next Year
- CDXS $34.28
- PINE $2.82
- P/E Ratio
- CDXS N/A
- PINE $206.04
- Revenue Growth
- CDXS N/A
- PINE 14.94
- 52 Week Low
- CDXS $1.90
- PINE $14.51
- 52 Week High
- CDXS $6.08
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- CDXS 44.61
- PINE 49.88
- Support Level
- CDXS $2.30
- PINE $14.66
- Resistance Level
- CDXS $2.56
- PINE $15.30
- Average True Range (ATR)
- CDXS 0.20
- PINE 0.26
- MACD
- CDXS -0.01
- PINE 0.07
- Stochastic Oscillator
- CDXS 46.67
- PINE 83.75
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.